Latest Announcements

Prime Fresh Limited reported robust Q1 FY27 operational performance with revenue from operations up 15.7% YoY to ¥61.71 Cr, EBITDA up 51.0% YoY to ¥6.07 Cr, and PAT up 50.8% YoY to ¥4.35 Cr. EBITDA margin improved by 230 bps YoY to 9.83% and PAT margin improved by 163 bps YoY to 7.05%. Sales tonnage reached 17,982 MT in Q1 FY27, up 68.0% YoY.

Windlas Biotech Ltd reported Q1 FY27 earnings with revenue of INR248 crores, a 18% Y-o-Y growth, driven by diversified business model, operational excellence, and customer trust. The company completed a buyback of INR47 crores and declared a dividend of INR13 crores.

Eveready Industries India Ltd reported Q1 FY27 earnings, with revenue at INR407.7 crores, a 9% YoY growth, and EBITDA margin of 15.1%. The company maintained its seventh consecutive quarter of year-on-year revenue growth, with the battery business delivering a strong quarter, recording 11.9% revenue growth.

Talbros Automotive Components Limited has announced its Q1 FY27 earnings conference call transcript, highlighting the company's strong performance in the Indian automotive industry, driven by demand for SUVs, premium vehicles, and new model launches.

Talbros Automotive Components Ltd has announced its Q1 FY27 earnings conference call transcript, highlighting the company's strong performance in the Indian automotive industry, with growth in passenger and commercial vehicle sales, and increasing adoption of electric vehicles.

Om Freight Forwarders Ltd reported Q1FY27 financial results with revenue jumping 105% YoY to Rs. 193.35 Cr, EBITDA increasing 104% YoY to Rs. 11.29 Cr, and PAT growing 126% YoY to Rs. 7.30 Cr.

Prakash Pipes Limited has announced its Q1 FY2027 financial results, with net sales of ₹241 crores, EBITDA of ₹27 crores, and PAT of ₹16 crores, registering growth of 19%, 47%, and 59% respectively over the corresponding quarter of the last financial year.

International Conveyors Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, showing revenue from operations of ₹3,780 lakhs, a 39.5% increase from the same period last year. The company's net profit after tax stood at ₹12,022 lakhs, a 123.5% increase from the same period last year.

Prakash Pipes Limited has announced its financial results for the quarter ended 30th June, 2026, with net sales of ₹241 crores, EBITDA of ₹27 crores, and profit after tax of ₹16 crores, registering growth of 19%, 47%, and 59% respectively over the corresponding quarter of the last financial year.

Rasi Electrodes Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, reporting a net profit of Rs. 133.45 lakhs, a 76.5% increase from the previous quarter's net profit of Rs. 75.57 lakhs. The company's revenue from operations stood at Rs. 1,763.57 lakhs, a 4.7% increase from the previous quarter's revenue of Rs. 1,856.39 lakhs.

Dev Information Technology Ltd has reported its unaudited financials for Q1 FY27, with consolidated total income of ₹44.64 Cr, EBITDA of ₹3.99 Cr, and net profit of ₹2.11 Cr.

Baroda Rayon Corporation Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, with a net profit of ₹1,847.27 lakhs, a 283% increase from the same period last year.

Natco Pharma Ltd announced unaudited financial results for Q1 FY27, with consolidated revenue of ₹794.4 Crore and profit after tax of ₹206.5 Crore. The company declared an interim dividend of ₹1.5 per equity share. The Board also approved the reconstitution of Risk Management Committee and Environment, Social and Governance Committee.

Prakash Pipes Ltd has announced unaudited financial results for the quarter ended 30.06.2026, with a net profit of ₹1,642 lakhs, a 21.5% increase from ₹1,348 lakhs in the previous quarter. The company has also approved a capacity expansion in the Flexible Packaging Division at Kashipur, involving a capital expenditure of around ₹100 Crores.

Meera Industries Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a profit before tax of ₹95.63 lakhs and a profit after tax of ₹71.34 lakhs. The company's revenue from operations was ₹1,234.59 lakhs, and its expenses were ₹1,158.82 lakhs. The results are available on the company's website and will be published in newspapers as per the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Globe Civil Projects Limited has announced its unaudited standalone and consolidated financial results for Q1 FY - 27, with a total income of ¥929 million and a PAT of ¥71 million. The company delivered a steady performance during Q1 FY - 27, supported by disciplined execution across ongoing EPC projects, efficient resource utilization, and continued focus on project delivery.

Lakshmi Mills Company Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, with a net profit of Rs. 5,014.99 lakhs. The company's income from operations was Rs. 5,971.91 lakhs, while its expenditure was Rs. 5,603.43 lakhs. The unaudited financial results were approved by the Board of Directors at their meeting held on 14th August 2026.

Globe Civil Projects Ltd has announced its unaudited standalone and consolidated financial results for Q1 FY 27, with total income of ¥929 million and PAT of ¥71 million, representing a 37.26% and 40.42% YoY growth respectively.

Alkem Laboratories Ltd reported a 10.9% YoY growth in total revenue from operations for Q1FY27, with a 11% revenue growth in Q1FY27. The company outperformed the Indian Pharmaceutical Market (IPM) in seven key focused therapies. The EBITDA margin was 20.5%, a growth of 3.7% YoY. The net profit (after Non-Controlling interest) was ₹5,200 million, with a YoY de-growth of 21.7%. The company has outperformed IPM in seven key focused therapies: Anti-infectives grew by ~1.1X; Gastro-intestinal grew by ~1.2X, VMN ~1.4X, Pain ~1.8X, Anti-Diabetic ~1.4X, Respiratory ~1.6X and Derma ~1.6X.

Alkem Laboratories Ltd. has announced its Q1FY27 financial results, with a 10.9% YoY growth in total revenue from operations. The company has outperformed the Indian Pharmaceutical Market (IPM) in several key therapies, and has received 05 ANDAs approvals in the US market. The company will hold a conference call on August 14, 2026, to discuss its financial results.